(Q39398543)

11 September 2017

title

Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis (English)

1 reference

11 September 2017

main subject

hepatocellular carcinoma

1 reference

1 reference

Sunyoung Chae

1

1 reference

11 September 2017

Young Bae Kim

series ordinal

2

1 reference

11 September 2017

Jong-Soo Lee

series ordinal

3

1 reference

11 September 2017

Hyeseong Cho

series ordinal

4

1 reference

11 September 2017

language of work or name

1 reference

9 February 2012

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

11 September 2017

published in

1 reference

11 September 2017

volume

302

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

G1016-24

1 reference

DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Unwinding the loop of Bcl-2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Regulation of apoptosis by Bcl‐2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Novel role for JNK as a stress-activated Bcl2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

BCL-2 family members and the mitochondria in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

DNA Damage, Aging, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Sorafenib for the treatment of unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Biology of SNU cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Molecular targeted therapy for hepatocellular carcinoma: bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Three distinct signalling responses by murine fibroblasts to genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Characterization of cell lines established from human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Integrating stress-response and cell-cycle checkpoint pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Opportunities for targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00449.2011

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00449.2011

1 reference

11 September 2017

1 reference